scholarly journals Social Determinant Trends of COVID-19: An Analysis Using Knowledge Graphs from Published Evidence and Online Trends

2021 ◽  
Author(s):  
Martin Gleize ◽  
Natasha Mulligan ◽  
Alessandro Di Bari ◽  
Joao H. Bettencourt-Silva
Keyword(s):  
Social Factors ◽  
Social Determinant ◽  
World Health ◽  
Knowledge Graph ◽  
Derived Relations ◽  
Published Evidence ◽  
The World ◽  
Online Searches ◽  
Knowledge Graphs ◽  
Health Organization

This paper presents the results of a new approach to discover related health and social factors during the COVID-19 pandemic. The approach leverages a knowledge graph of related concepts mined from a corpus of published evidence (PubMed) prior to the pandemic. Population trends from online searches were used to identify social determinants of health (SDoH) concepts that trended high at the outset of the pandemic from a list of SDoH topics from the World Health Organization (WHO). The trending concepts were then mapped to the knowledge graph and a subsequent analysis of the derived insights, spanning two years, was conducted. This paper suggests an approach to derive new related health and social factors that may have either played a role in, or been affected by, the onset of the global COVID-19 pandemic. In particular, our results show how, from a list of SDoH topics, Food Security, Unemployment trended the highest at the start of the pandemic. Further work is needed to continue to ascertain the validity of the derived relations in a population health context and to improve mining insights from published evidence.

scholarly journals Antenatal care, care at birth, and breastfeeding during the Coronavirus (COVID-19) pandemic

2020 ◽  
Vol 32 (1) ◽  
pp. 15-18
Author(s):  
Ranjitha Ranganathan ◽  
Amir Maroof Khan ◽  
Pragti Chhabra
Keyword(s):  
Antenatal Care ◽  
Healthcare Workers ◽  
Scientific Information ◽  
World Health ◽  
Vulnerable Group ◽  
Published Evidence ◽  
Lactating Mothers ◽  
The World ◽  
Child Healthcare ◽  
Health Organization

Coronavirus (COVID-19) pandemic has been declared by the World Health Organization after it has gripped many countries of the world. The exponential increase in the number of cases has resulted in panic and confusion among healthcare workers and the vulnerable population. Pregnant and lactating mothers are a vulnerable group and need evidence-based advice to protect the health of the mother and the child. Healthcare workers can play an important role in dispelling the myths and misconceptions among pregnant and lactating mothers regarding COVID-19, if they are equipped with scientific information on antenatal care, care at birth, and breastfeeding. This review attempts to summarize the published evidence related to antenatal care, care at birth and breastfeeding during the COVID-19 pandemic.

Drug Withdrawal Due to Safety: A Review of the Data Supporting Withdrawal Decision

2020 ◽  
Vol 15 (1) ◽  
pp. 4-12 ◽  
Author(s):  
Nuno Sales Craveiro ◽  
Bruno Silva Lopes ◽  
Lara Tomás ◽  
Sofia Fraga Almeida
Keyword(s):  
World Health Organization ◽  
Drug Exposure ◽  
Information Sources ◽  
Drug Withdrawal ◽  
World Health ◽  
Published Evidence ◽  
Spontaneous Reports ◽  
Drug Databases ◽  
The World ◽  
Health Organization

Introduction: Several drugs were withdrawn from the market due to safety. Objective: The aim of this study was to describe data supporting drug withdrawal from the market due to safety reasons in countries belonging to the World Health Organization. Methods: We analyzed drugs withdrawn from the market between 1990 and 2010. All medicine agencies of the countries belonging to the Program for International Drug Monitoring of the World Health Organization were contacted. To complete data, Medline, reference books and available drug databases were also searched. Information sources on which authorities based their withdrawal were categorized and the average time between the first date of exposure and withdrawal was calculated and stratified. Results: A total of 133 drugs that met the inclusion/exclusion criteria were withdrawn from the market due to safety reasons in the period reviewed (1990 - 2010). Hepatotoxicity (n=36, 27.1%), cardiac disorders (n=25, 18.8%), hypersensitivity (n=17, 12.8%) and nephrotoxicity (n=14, 9.8%) were the major reasons responsible for 69.2% of all drugs withdrawn. In most cases, Information Sources for drug withdrawal were spontaneous reports and/or case reports (n=86, 64.7%), followed by clinical trials (n=24, 18.0%). The average time between the introduction of a drug and its withdrawal due to safety reasons was 20.3 years (SD±13.8). Conclusion: According to available and published evidence, there is no gold standard to identify risks associated with drug exposure. These findings strengthen the role of different information sources within the drug safety review process.

Erstes Instrument zur standardisierten Erfassung der Teilhabe Behinderter

2017 ◽  
Vol 79 (07) ◽  
pp. 526-527
Keyword(s):  
World Health Organization ◽  
World Health ◽  
The World ◽  
Health Organization ◽  
Menschen Mit Behinderung

Coenen M et al. [Recommendation for the collection and analysis of data on participation and disability from the perspective of the World Health Organization]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2016; 59: 1060–1067 Um eine gleichberechtigte Teilhabe an der Gesellschaft von Menschen mit Behinderung zu ermöglichen, werden zunächst Daten zu vorhandenen Einschränkungen gebraucht. Erst wenn diese detailliert erhoben wurden, können Konzepte zur Beseitigung von Problemen entwickelt werden. Ein standardisiertes Erhebungsinstrument für alle Aspekte der Funktionsfähigkeit fehlte jedoch bisher.

Coronavirus diseases and pregnancy: COVID-19,SARS, and MERS

2020 ◽  
pp. 276-289
Author(s):  
Mobina Fathi ◽  
Kimia Vakili ◽  
Niloofar Deravi
Keyword(s):  
Pregnant Women ◽  
Intrauterine Growth Retardation ◽  
Negative Impact ◽  
World Health ◽  
Wuhan City ◽  
Intrauterine Growth ◽  
Exponential Increase ◽  
The World ◽  
Health Organization ◽  
Respiratory Droplets

Around the end of December 2019, a new beta-coronavirus from Wuhan City, Hubei Province, China began to spread rapidly. The new virus, called SARS-CoV-2, which could be transmitted through respiratory droplets, had a range of mild to severe symptoms, from simple cold in some cases to death in others. The disease caused by SARS-CoV-2 was named COVID-19 by WHO and has so far killed more people than SARS and MERS. Following the widespread global outbreak of COVID-19, with more than 132758 confirmed cases and 4955 deaths worldwide, the World Health Organization declared COVID-19 a pandemic disease in January 2020. Earlier studies on viral pneumonia epidemics has shown that pregnant women are at greater risk than others. During pregnancy, the pregnant woman is more prone to infectious diseases. Research on both SARS-CoV and MERS-CoV, which are pathologically similar to SARS-CoV-2, has shown that being infected with these viruses during pregnancy increases the risk of maternal death, stillbirth, intrauterine growth retardation and, preterm delivery. With the exponential increase in cases of COVID-19 throughout the world, there is a need to understand the effects of SARS-CoV-2 on the health of pregnant women, through extrapolation of earlier studies that have been conducted on pregnant women infected with SARS-CoV, and MERS-CoV. There is an urgent need to understand the chance of vertical transmission of SARS-CoV-2 from mother to fetus and the possibility of the virus crossing the placental barrier. Additionally, since some viral diseases and antiviral drugs may have a negative impact on the mother and fetus, in which case, pregnant women need special attention for the prevention, diagnosis, and treatment of COVID-19.

COVID 19: REALS AND CHALLENGES AGAINST DOCTORS

2020 ◽  
Vol 2 (1) ◽  
pp. 65-87
Author(s):  
Zen Ahmad
Keyword(s):  
Virus Disease ◽  
Clinical Manifestations ◽  
World Health ◽  
Unknown Etiology ◽  
Wuhan City ◽  
Traditional Markets ◽  
Pneumonia Case ◽  
The World ◽  
New Type ◽  
Health Organization

Corona Virus Disease (Covid-19) is a contagious disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which was discovered in December 2019 in China. This disease can cause clinical manifestations in the airway, lung and systemic. The World Health Organization (WHO) representative of China reported a pneumonia case with unknown etiology in Wuhan City, Hubei Province, China on December 31, 2019. The cause was identified as a new type of coronavirus on January 7, 2020 with an estimated source of the virus from traditional markets (seafood market). ) Wuhan city

Sign in / Sign up

Export Citation Format

Share Document